Sensata Technologies Holding PLC (ST) Stock News

Rosen Law Firm is reminding POET Technologies Inc. investors who purchased securities between April 1, 2026 and April 27, 2026 of the June 29, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that POET Technologies made false statements regarding its tax status as a potential passive foreign investment company (PFIC), failed to disclose negative tax implications for U.S. stockholders, and that a defendant violated a non-disclosure agreement by discussing business agreements publicly.

Rosen Law Firm is reminding investors who purchased Via Transportation, Inc. (NYSE: VIA) stock during its IPO about an August 10, 2026 deadline to join a securities class action lawsuit. The complaint alleges that Via's IPO offering documents were false and misleading, omitting information about declining Platform Annual Run-Rate Revenue and growth obstacles in Germany. Via shares have declined approximately 70% from the IPO price to $14.52.

Erasca, Inc. faces a securities class action lawsuit alleging that the company and its executives made false statements about its lead drug candidate ERAS-0015. The lawsuit claims preclinical data was based on improper comparisons and lacked reasonable basis. On April 27, 2026, Erasca disclosed a patent infringement assertion from Revolution Medicines and reported a patient death in Phase I trials, causing the stock to plummet nearly 59% over two trading days. Investors with substantial losses can seek appointment as lead plaintiff by August 10, 2026.

Rosen Law Firm has filed class action lawsuits against Black Rock Coffee Bar, Inc. (BRCB), GeneDx Holdings Corp. (WGS), and SES AI Corporation (SES) on behalf of investors who purchased securities during specified periods. The lawsuits allege that defendants made materially false and misleading statements regarding business operations and prospects. Black Rock Coffee is specifically accused of failing to disclose that new store openings caused cannibalization of existing revenue and overstating its expansion strategy effectiveness.

Rosen Law Firm is soliciting investors who purchased GeneDx Holdings Corp. (NASDAQ: WGS) stock between April 16, 2025 and May 4, 2026 to join a securities class action lawsuit. The lawsuit alleges that GeneDx made false statements regarding the Fabric acquisition's positive impact on the company's financials and operations, when in reality the company knew of significant viability problems that would negatively impact the business. The lead plaintiff deadline is August 3, 2026.

Rosen Law Firm announces a securities class action lawsuit against SES AI Corporation (NYSE: SES) for investors who purchased securities between January 29, 2025 and March 4, 2026. The lawsuit alleges that SES AI made materially false and misleading statements regarding business prospects, overstated expected results from business deals, created artificial revenue through circular transactions, and failed to disclose material logistics constraints affecting Q4 2025 revenues. The lead plaintiff deadline is June 26, 2026.

Rosen Law Firm announces a July 28, 2026 deadline for investors to join a securities class action against Lucid Group, Inc. The lawsuit alleges that Lucid made false statements regarding supplier quality issues that disrupted Gravity deliveries and overstated manufacturing capabilities, resulting in material negative impact on the company's business and financial results.

Rosen Law Firm is notifying Phreesia, Inc. investors who purchased stock between May 8, 2025 and March 30, 2026 of an important July 13, 2026 deadline to serve as lead plaintiff in a securities class action. The lawsuit alleges that Phreesia made false statements and concealed material facts regarding slowing demand and weakened pharmaceutical marketing commitments in its Network Solutions segment, resulting in investor damages.

A class action lawsuit has been filed against ADMA Biologics for allegedly making false statements regarding revenue growth, engaging in channel stuffing, failing to disclose related party transactions, and lacking adequate internal controls. A short-seller report triggered a 16% stock decline, followed by a 13% drop after a downgrade from Cantor Fitzgerald.

A securities class action lawsuit has been filed against Zoetis Inc. for allegedly making false and misleading statements about its Companion Animal products during January 14, 2025 to May 6, 2026. The lawsuit claims the company failed to disclose weakening veterinarian adoption of its Librela pain treatment following FDA safety warnings, significant market share losses in Simparica Trio to competitors, and declining market share in dermatology products Apoquel and Cytopoint. Investors with losses exceeding $100,000 are encouraged to join the class action before the July 27, 2026 lead plaintiff deadline.

A class action lawsuit has been filed against Sportradar Group AG alleging the company made false statements about its compliance practices and intentionally partnered with black-market gambling operators to boost revenues. The allegations emerged after investigative reports by Muddy Waters Research and Callisto Research on April 22, 2026, causing Sportradar's stock to fall over 22%. Investors who purchased shares between November 7, 2024 and April 21, 2026 can seek appointment as lead plaintiff by July 17, 2026.

Rosen Law Firm is reminding investors who purchased Verra Mobility Corporation (VRRM) stock between February 24, 2026 and May 26, 2026 of an August 4, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Verra made materially false and misleading statements regarding its relationship with Avis Budget Group and contract extension prospects, while downplaying risks of major rental car companies developing in-house solutions.

Rosen Law Firm has filed securities class action lawsuits against Graphic Packaging Holding Company, Sportradar Group AG, and FS KKR Capital Corp., alleging that defendants made false or misleading statements regarding their financial performance and business conditions. Investors with losses exceeding $100,000 are encouraged to join the class actions before the July 6, 2026 lead plaintiff deadline.

Rosen Law Firm has issued multiple securities class action deadline alerts for investors. The primary case involves Sportradar Group AG (SRAD), where investors who purchased shares between November 7, 2024 and April 21, 2026 may be entitled to compensation. The lawsuit alleges that Sportradar made false statements about compliance and worked with black-market gambling operators while claiming strict regulatory adherence. The lead plaintiff deadline is July 17, 2026. Similar deadline alerts were also issued for FS KKR Capital Corp. (FSK) and Regencell Bioscience Holdings Limited (RGC).

Via Transportation, Inc. faces a class action lawsuit alleging its September 2025 IPO offering documents were materially false and misleading. The company allegedly concealed declining revenue per customer and regulatory issues in Germany. Stock has dropped approximately 70% below the IPO price of $46 following successive negative earnings announcements. Investors with substantial losses have until August 10, 2026 to seek lead plaintiff status.

Law firm Bronstein, Gewirtz & Grossman, LLC announced an investigation into Gildan Activewear Inc. following a Jehoshaphat Research report alleging channel stuffing, revenue manipulation, and off-balance-sheet financial engineering. The allegations caused Gildan's stock to fall 18.8% on June 16, 2026. The firm is seeking investors who purchased Gildan securities to participate in the investigation.

Rosen Law Firm is reminding investors in Regencell Bioscience Holdings Limited (RGC) and AeroVironment, Inc. (AVAV) of upcoming lead plaintiff deadlines in securities class action lawsuits. The lawsuits allege that defendants made false or misleading statements regarding market manipulation vulnerabilities, regulatory risks, and financial exposure during their respective class periods.

Rosen Law Firm has filed a class action lawsuit against BitGo Holdings, Inc. on behalf of investors who purchased securities during the company's January 2026 IPO and through May 13, 2026. The lawsuit alleges that BitGo's offering documents contained materially false and misleading statements, specifically understating risks related to declining digital asset prices and their impact on the company's business and financial performance. Investors must move the court by August 7, 2026 to serve as lead plaintiff.

Rosen Law Firm has filed a securities class action lawsuit against POET Technologies Inc. for allegedly making false and misleading statements regarding its tax status as a potential passive foreign investment company (PFIC), failing to disclose negative tax implications for U.S. stockholders, and an executive's violation of a non-disclosure agreement. Investors with losses exceeding $100,000 are encouraged to join the class action before the June 29, 2026 deadline.

Rosen Law Firm has filed a class action lawsuit against Zillow Group on behalf of investors who purchased Class A or Class C common stock between February 11, 2025 and May 7, 2026. The lawsuit alleges that Zillow made materially false and misleading statements regarding its agreement with Redfin Corporation, mischaracterizing it as a partnership rather than an acquisition, and failed to disclose heightened regulatory and antitrust risks. The deadline to serve as lead plaintiff is August 10, 2026.

First United Corporation (NASDAQ:FUNC) announced that its Board of Directors declared a cash dividend of $0.26 per share, payable on August 3, 2026, to shareholders of record as of July 20, 2026.

AST SpaceMobile and Joby Aviation represent high-growth investments in emerging transportation and communication technologies. AST SpaceMobile provides satellite-to-phone broadband connectivity with partnerships across 50+ mobile operators, while Joby Aviation develops electric vertical takeoff aircraft for urban air mobility. Both companies face significant losses and regulatory hurdles, but AST SpaceMobile is recommended as the better near-term investment due to its clearer path to commercialization and existing operator partnerships.

The space sector rebounds Wednesday as Momentus and AST SpaceMobile lead gains following positive catalysts. Momentus announced a new contract with University of Colorado Boulder for its Vigoride-9 service vehicle, rising 9.04%. AST SpaceMobile successfully launched three BlueBird satellites, gaining 6.75%. The sector recovers after SpaceX's IPO triggered a broader selloff, with investors showing renewed interest in commercial space companies.

Avalyn Pharma announced completion of target enrollment of 375 patients in the Phase 2b MIST clinical trial of AP01 (inhaled pirfenidone) for progressive pulmonary fibrosis. The global, randomized, double-blinded, placebo-controlled trial is evaluating two doses of AP01 against placebo, with primary endpoint measuring change in lung function at 52 weeks. Topline data is expected in the second half of 2027.

The space sector is catching its breath Wednesday — and for the first time since SpaceX (NASDAQ: SPCX ) went public last week and triggered a sector-wide selloff, many publicly traded space names are green. Momentus Inc. (NASDAQ: MNTS ) and AST SpaceMobile, Inc. (NASDAQ: ASTS ) are leading the charge with specific catalysts behind their moves.  ASTS stock is climbing. See the chart and price action here. Momentus’ New Contract Monmentus shares are up 9.04% to $10.15 intraday. Wednesday's strength follows a new contract announcement with the University of Colorado Boulder’s Laboratory for Atmospheric and Space Physics, where Momentus will host and operate the Occultation Wave Limb Sounder mission aboard its Vigoride-9 Orbital Service Vehicle.  The deal adds an academic customer to a roster that already includes NASA and the U.S. Department of Defense. MNTS stock remains up more than 100% year-to-date despite a 27% drop on June 12 after pricing a $25 million registered direct offering. data-variant="card" ... Full story available on Benzinga.com

SpaceX's IPO has driven its stock from $135 to over $225, creating a $2.5 trillion valuation driven by retail options trading and float scarcity rather than fundamentals. The company trades at 20x projected 2027 sales while posting $4.94 billion annual losses. A $60 billion all-stock acquisition of Cursor and Tesla merger rumors inflate valuations further. Meanwhile, AST SpaceMobile and Rocket Lab offer better risk-reward profiles after being temporarily overshadowed by the SpaceX IPO frenzy.

Kustom Entertainment (NASDAQ:KUST) shares surged 11.26% after-hours to $1.68 following strong ticket sales announcements for Country Stampede Kansas 2026. Thursday tickets sold out completely, Friday is 90% sold out, and Saturday is 70% sold out. The rally was also driven by a partnership announcement with Gilley's Gambling Hall to host Country Stampede 2027 and other events, expanding the company's presence in the Wichita market.

Rosen Law Firm has filed a class action lawsuit against Nano-X Imaging Ltd. (NNOX) on behalf of investors who purchased securities between March 31, 2025 and April 17, 2026. The lawsuit alleges that defendants made false and misleading statements regarding operational efficiency gains and product demand, while concealing poor alignment between production and demand, increased operating expenses, and significant cash burn that necessitated restructuring measures.

Pomerantz LLP is investigating Biogen Inc. for potential securities fraud following the company's announcement of Phase 2 CELIA study results for diranersen (BIIB080), an Alzheimer's disease treatment. Although Biogen described the results as 'compelling,' the study missed its primary dose-response endpoint, causing the stock to fall $13.16 per share (6.43%) to $191.37 on May 14, 2026.

BP's board unanimously removed Chair and Director Albert Manifold on May 26, 2026, citing serious governance, oversight, and conduct concerns. The announcement triggered a 3.85% decline in BP's American Depositary Share price, falling $1.71 to $42.65. Pomerantz LLP is investigating potential securities fraud and unlawful business practices.